Investigating the rate of clearance of ranibizumab and aflibercept from the eye

Update Il y a 4 ans
Reference: EUCTR2012-005500-18

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To study the effect of pars plana vitrectomy on the half-life of ranibizumab and to compare the half-life of ranibizumab and aflibercept.


Inclusion criteria

  • Age-related macular degeneration

Links